Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NextTrip, Inc. Director's Dealing 2022

Aug 12, 2022

34837_dirs_2022-08-11_91511b43-fc20-4d0b-be0f-daf4dd0cddb6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SIGMA LABS, INC. (SASI)
CIK: 0000788611
Period of Report: 2022-08-09

Reporting Person: Fisher Ronald Kenneth Jr (VP of Business Development)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-08-09 Stock Option (right to buy) $2.50 A 1751 Acquired 2027-07-01 Common Stock (1751) Direct

Footnotes

F1: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on August 9, 2022.

F2: The stock option vests as follows: (i) 438 shares subject to the option vested on the date of grant, and (ii) the remaining 1,313 shares will vest in equal (as nearly as possible) monthly installments over the succeeding 36 months, subject, in each case, to the Reporting Person remaining an employee of the Issuer on the applicable vesting date.